Since the p95 fragment has also been detected in breast cancer specimens, it has been suggested that shedding of the ECD may represent an alternative activation mechanism of Her-2/neuin vivo (Christianson et al, 1998). This evidence concerns the gene ERBB2 and breast carcinoma.